Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study (2014)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1007/s00702-013-1088-8
- Subjects: EXPRESSÃO GÊNICA; DOENÇA DE ALZHEIMER; COGNIÇÃO (DEFICIÊNCIA)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Neural Transmission
- ISSN: 0300-9564
- Volume/Número/Paginação/Ano: v. 121, n. 2, p. 193-200, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
GATTAZ, Wagner F. et al. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study. Journal of Neural Transmission, v. 121, n. 2, p. 193-200, 2014Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00702-013-1088-8. Acesso em: 29 set. 2024. -
APA
Gattaz, W. F., Talib, L. L., Schaeffer, E. L., Diniz, B. S., & Forlenza, O. V. (2014). Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study. Journal of Neural Transmission, 121( 2), 193-200. doi:10.1007/s00702-013-1088-8 -
NLM
Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study [Internet]. Journal of Neural Transmission. 2014 ; 121( 2): 193-200.[citado 2024 set. 29 ] Available from: http://link.springer.com/article/10.1007/s00702-013-1088-8 -
Vancouver
Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study [Internet]. Journal of Neural Transmission. 2014 ; 121( 2): 193-200.[citado 2024 set. 29 ] Available from: http://link.springer.com/article/10.1007/s00702-013-1088-8 - Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
- Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease
- Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
- Long-term, low-dose lithium treatment does not impair renal functional in the elderly: A 2 year randomized, placebo-controlled trial followed by single blind extension
- Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
Informações sobre o DOI: 10.1007/s00702-013-1088-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
